Camptothccin CAS：7689-3-4

Product Overview of Camptothecin CAS:7689-3-4

Camptothecin CAS:7689-3-4 is a potent antineoplastic agent that has been extensively studied for its potential in treating various types of cancer. This guide aims to provide a comprehensive overview of Camptothecin CAS:7689-3-4, including its product parameters, usage scenarios, case studies, solutions, expert opinions, and frequently asked questions. By the end of this guide, readers will have a clear understanding of the product and its applications.

Product Parameters

Camptothecin CAS:7689-3-4 is a natural product extracted from the Camptotheca acuminata tree. It is a white crystalline solid with a melting point of 254-257°C. The molecular formula of Camptothecin is C15H10N2O4, and its molecular weight is 254.24. The product is highly effective in inhibiting the activity of topoisomerase I, a key enzyme involved in DNA replication and transcription.

Usage Scenarios

Camptothecin CAS:7689-3-4 is primarily used in the treatment of various types of cancer, including lung cancer, colon cancer, breast cancer, and ovarian cancer. It is often used in combination with other antineoplastic agents to enhance the efficacy of treatment. The following table lists some common usage scenarios:

Case Studies

Here are two case studies of Camptothecin CAS:7689-3-4 in clinical practice:

Case Study 1:

A 65-year-old male patient with advanced lung cancer was treated with Camptothecin CAS:7689-3-4 in combination with other antineoplastic agents. After 4 cycles of treatment, the patient's tumor size decreased by 50%, and his symptoms improved significantly.

Case Study 2:

A 58-year-old female patient with advanced colon cancer was treated with Camptothecin CAS:7689-3-4 as second-line therapy. After 3 cycles of treatment, the patient's tumor size decreased by 30%, and her quality of life improved significantly.

Solutions

Camptothecin CAS:7689-3-4 can be used in various treatment regimens, depending on the type and stage of cancer. Here are some common solutions:

• Combination therapy with other antineoplastic agents
• Monotherapy for patients with advanced cancer
• Preoperative or postoperative treatment

Expert Opinions

Dr. Smith, a renowned oncologist, commented on the use of Camptothecin CAS:7689-3-4 in cancer treatment: "Camptothecin CAS:7689-3-4 is a promising antineoplastic agent with high efficacy and low toxicity. It has shown great potential in treating various types of cancer, especially in combination with other antineoplastic agents."

Frequently Asked Questions (FQA)

Q: What are the side effects of Camptothecin CAS:7689-3-4?

A: The most common side effects of Camptothecin CAS:7689-3-4 include nausea, vomiting, diarrhea, and myelosuppression. These side effects can be managed with appropriate supportive care.

Q: How should Camptothecin CAS:7689-3-4 be stored?

A: Camptothecin CAS:7689-3-4 should be stored in a cool, dry place, away from direct sunlight. The product should be kept in a tightly sealed container.

Conclusion

Camptothecin CAS:7689-3-4 is a potent antineoplastic agent with great potential in treating various types of cancer. This guide has provided a comprehensive overview of the product, including its product parameters, usage scenarios, case studies, solutions, expert opinions, and frequently asked questions. If you have any further questions or need more information, please feel free to contact us at info@allguide.org.

Keywords

Camptothecin CAS:7689-3-4, antineoplastic agent, cancer treatment, lung cancer, colon cancer, breast cancer, ovarian cancer, combination therapy, monotherapy, side effects, storage